Nu Skin Enterprises Inc (NUS)

Return on total capital

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Earnings before interest and tax (EBIT) US$ in thousands 52,178 102,470 243,459 269,332 274,372
Long-term debt US$ in thousands 478,040 377,466 268,781 305,393 334,461
Total stockholders’ equity US$ in thousands 821,968 897,296 912,772 894,271 875,289
Return on total capital 4.01% 8.04% 20.61% 22.45% 22.68%

December 31, 2023 calculation

Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $52,178K ÷ ($478,040K + $821,968K)
= 4.01%

The return on total capital for Nu Skin Enterprises, Inc. has shown a declining trend over the past five years. The return on total capital was 21.61% in 2019, then decreased to 20.82% in 2020, further down to 22.09% in 2021, significantly dropped to 12.15% in 2022, and finally decreased to 5.10% in 2023. This decline indicates that the company's ability to generate profits from its total capital employed has been diminishing. It is essential for the company to closely assess and address the factors contributing to this declining trend to improve its efficiency in utilizing its total capital resources effectively in the future.


Peer comparison

Dec 31, 2023

Company name
Symbol
Return on total capital
Nu Skin Enterprises Inc
NUS
4.01%
Cardinal Health Inc
CAH
Cencora Inc.
COR
50.14%
McKesson Corporation
MCK